Article 2 Amendment of the Medicines (Advisory Board on the Registration of Homoeopathic Products) Order 1995

(1)

The Medicines (Advisory Board on the Registration of Homoeopathic Products) Order 1995^f1 is amended as follows.

(2)

In article 1 (citation, commencement and interpretation), in paragraph (2), after the definition of “homoeopathic medicinal product” insert the following definitions—

““marketing authorization” means a marketing authorization for a national homoeopathic product granted by the licensing authority under the Marketing Authorisation Regulations^f2;

“national homoeopathic product” has the same meaning as in regulation 4(1B) of the Marketing Authorisation Regulations;”.

(3)

In article 2 (Advisory Board on the Registration of Homoeopathic Products)—

(a)

in paragraph (1), for the words from “the safety and quality of” to the end, substitute—

“—

(a)
the safety and quality of any homoeopathic medicinal product—

(i)
in respect of which a certificate of registration has been granted, or

(ii)
which is the subject of an application for such a certificate; and

(b)
the safety, quality and efficacy of any homoeopathic medicinal product—

(i)
in respect of which a marketing authorization has been granted,

(ii)
which is the subject of an application for such an authorization, or

(iii)
in respect of which a licence of right has been granted.”; and

(b)

omit paragraph (2).

Annotations

Footnotes

f1: S.I. 1995/309, amended by S.I. 2002/236 and 2005/2753.
f2: S.I. 1994/3144 as amended by S.I. 2006/1952 ; see the definition of “the Marketing Authorisation Regulations” in section 132(1) of the Medicines Act 1968, as inserted by S.I. 2005/1094.